Cargando…
In vivo evolution of tumour cells after the generation of double-strand DNA breaks
In vitro, the ratio of single- to double-strand DNA breaks (DSB) and their absolute values determine the cell death pathway. The consequences of the generation of various numbers of DSB generated in vivo in tumour cells have been analysed in two different experimental tumour models. Synchronisation...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377151/ https://www.ncbi.nlm.nih.gov/pubmed/12771993 http://dx.doi.org/10.1038/sj.bjc.6600959 |
_version_ | 1782154789534040064 |
---|---|
author | Mekid, H Tounekti, O Spatz, A Cemazar, M El Kebir, F Z Mir, L M |
author_facet | Mekid, H Tounekti, O Spatz, A Cemazar, M El Kebir, F Z Mir, L M |
author_sort | Mekid, H |
collection | PubMed |
description | In vitro, the ratio of single- to double-strand DNA breaks (DSB) and their absolute values determine the cell death pathway. The consequences of the generation of various numbers of DSB generated in vivo in tumour cells have been analysed in two different experimental tumour models. Synchronisation of DSB generation and control of their number have been achieved using different doses of bleomycin (BLM) and tumour cell permeabilisation by means of locally delivered electric pulses. According to BLM dose, different cell death pathways are observed. At a low therapeutic dose, a mitotic cell death pathway is detected. It is characterised by the appearance of ‘atypical mitosis’, TUNEL and caspase-3 positive, 24 h after the treatment, and later by the presence of typical apoptotic figures, mainly TUNEL positive but caspase-3 negative. Caspase-3 is thus an early marker of apoptosis. Mitotic cell death is also followed by lymphocytic infiltration reaction. At high doses of BLM, pseudoapoptosis is detected within a few minutes after the treatment. These cell death pathways are discussed as a function of the number of DSB generated, by comparison with previous results obtained in vitro using BLM or ionising radiation. |
format | Text |
id | pubmed-2377151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23771512009-09-10 In vivo evolution of tumour cells after the generation of double-strand DNA breaks Mekid, H Tounekti, O Spatz, A Cemazar, M El Kebir, F Z Mir, L M Br J Cancer Experimental Therapeutics In vitro, the ratio of single- to double-strand DNA breaks (DSB) and their absolute values determine the cell death pathway. The consequences of the generation of various numbers of DSB generated in vivo in tumour cells have been analysed in two different experimental tumour models. Synchronisation of DSB generation and control of their number have been achieved using different doses of bleomycin (BLM) and tumour cell permeabilisation by means of locally delivered electric pulses. According to BLM dose, different cell death pathways are observed. At a low therapeutic dose, a mitotic cell death pathway is detected. It is characterised by the appearance of ‘atypical mitosis’, TUNEL and caspase-3 positive, 24 h after the treatment, and later by the presence of typical apoptotic figures, mainly TUNEL positive but caspase-3 negative. Caspase-3 is thus an early marker of apoptosis. Mitotic cell death is also followed by lymphocytic infiltration reaction. At high doses of BLM, pseudoapoptosis is detected within a few minutes after the treatment. These cell death pathways are discussed as a function of the number of DSB generated, by comparison with previous results obtained in vitro using BLM or ionising radiation. Nature Publishing Group 2003-06-02 2003-05-27 /pmc/articles/PMC2377151/ /pubmed/12771993 http://dx.doi.org/10.1038/sj.bjc.6600959 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Experimental Therapeutics Mekid, H Tounekti, O Spatz, A Cemazar, M El Kebir, F Z Mir, L M In vivo evolution of tumour cells after the generation of double-strand DNA breaks |
title | In vivo evolution of tumour cells after the generation of double-strand DNA breaks |
title_full | In vivo evolution of tumour cells after the generation of double-strand DNA breaks |
title_fullStr | In vivo evolution of tumour cells after the generation of double-strand DNA breaks |
title_full_unstemmed | In vivo evolution of tumour cells after the generation of double-strand DNA breaks |
title_short | In vivo evolution of tumour cells after the generation of double-strand DNA breaks |
title_sort | in vivo evolution of tumour cells after the generation of double-strand dna breaks |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377151/ https://www.ncbi.nlm.nih.gov/pubmed/12771993 http://dx.doi.org/10.1038/sj.bjc.6600959 |
work_keys_str_mv | AT mekidh invivoevolutionoftumourcellsafterthegenerationofdoublestranddnabreaks AT tounektio invivoevolutionoftumourcellsafterthegenerationofdoublestranddnabreaks AT spatza invivoevolutionoftumourcellsafterthegenerationofdoublestranddnabreaks AT cemazarm invivoevolutionoftumourcellsafterthegenerationofdoublestranddnabreaks AT elkebirfz invivoevolutionoftumourcellsafterthegenerationofdoublestranddnabreaks AT mirlm invivoevolutionoftumourcellsafterthegenerationofdoublestranddnabreaks |